source
- On second try, Acadia drug gets nod from European regulatorsThe influential CHMP committee also threw its support behind more than a dozen other medicines while recommending the marketing authorization for Tavneos be revoked.BioPharma Dive · 1mo ago↗ source
- De-Risking a Rare Disease Launch Starts with PrecisionWhy traditional models fall short in rare disease commercialization—and what works instead.Fierce Biotech · 1mo ago↗ source
- Opinion: Why the space in ‘health care’ mattersWhen STAT polled our readers on ‘health care’ vs. ‘healthcare,’ about 60% of our readers voted for one word.STAT · 1mo ago↗ source